Pharmaceutical Intermediates Market Growing at a CAGR of 7.2% from 2023 to 2032, Driven by Growing Prevalence of Chronic and Infectious Diseases | overviewSLICE

The Global Pharmaceutical intermediates the market size was estimated at US$29.5 billion in 2021 and is expected to grow at a CAGR of 7.2% Between 2023 to 2032.

Pharmaceutical intermediates are chemicals that are used as raw materials in the manufacture of finished drugs. Additionally, they are commonly used to refer to a material formed during the manufacture of an active pharmaceutical ingredient (API) prior to purification of the API.

Access the sample report:

Pharmaceutical intermediates are often made from high quality base ingredients. They are frequently used in the pharmaceutical and cosmetic sectors.

Pesticides, drugs, plasticizers, preservatives and resins are all made from medicinal compounds. The global demand for pharmaceutical components is increasing rapidly as research and development efforts increase.

Key Players of the Global Pharmaceutical Intermediates Market are:

The global pharmaceutical intermediates market is highly competitive, with few prominent competitors. Aceto Corporation, BASF SE, Codexis, Inc., Chiracon GmbH, Dishman Group, Green Vision Life Sciences, Sanofi SAIS, Vertellus Holdings LLC., and others, including Yin-sheng Bio-tech Co., Ltd., have an important market to share.

Driving factors for the growth of the global pharmaceutical intermediates market

Prominent biotech and pharmaceutical manufacturers are striving to expand the reach of their products globally. These companies are focused on expanding the distribution of their products in various countries around the world using multiple distribution channels.

As a result, the pharmaceutical intermediates market growth forecast will remain favorable as companies continue to focus on expanding the capacities of their production facilities in various parts of the world.

Furthermore, as production technology develops and the global chemical industry expands, consumer spending on pharmaceutical intermediates increases. They are generated on demand for bulk and custom operations since they are basically intermediate products of specific industries.

Several small and medium-sized companies are also working on increasing their manufacturing capacity, which is expected to boost the development of the pharmaceutical intermediates market. As a result, the consumption of pharmaceutical intermediates is increasing and sales are expected to increase significantly by 2030.

Learn more about the report inclusions:

Key segments of the global pharmaceutical intermediates market:

By product:

    • Chiral intermediate
    • Achiral intermediate

On demand:

  • Cardiology
  • Oncology
  • Endocrinology
  • Infectious diseases
  • Orthopedics
  • Neurology
  • Gastroenterology
  • Dermatology
  • Inflammation and pain management
  • Ophthalmology
  • Others

Per end user:

  • Pharmaceutical and biotechnology companies
  • CROs and CMOs

By geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • The rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East and Africa
  • South America
    • Brazil
    • Rest of South America

Major Market Segments of Global Pharmaceutical Intermediates Market

Rising prevalence of chronic diseases, prioritization of R&D by major players, and competitive business strategies are the key drivers expected to propel the expansion of the global pharmaceutical intermediates market throughout the forecast period.

Popular Applications of Pharmaceutical Intermediates

Currently, pharmaceutical intermediates are used to treat heart problems such as tachycardia. Medical development and research will uncover new applications for these intermediates, creating more profitable prospects in this industry internationally.

The growing demand for pharmaceutical intermediates is driven by the increased demand for the treatment of chronic diseases. Additionally, rising instances of contagious diseases will drive up the demand for APIs in the coming years, bolstering the expansion of the global pharmaceutical intermediates market.

There is an increase in medical scientific research funding caused by an increase in demand for new drugs for COVID-19 and inflammatory conditions due to which the pharmaceutical intermediates market is expected to grow.

Greater awareness of chronic diseases among physicians and patients, along with increasing public and private healthcare expenditures, have fueled the expansion of the market.

Furthermore, technological improvements such as high throughput, bioinformatics and computational chemistry for efficient identification of drug candidates are creating a market for pharmaceutical intermediates for research applications.

Due to increased production and research efforts in the pharmaceutical sector, the availability and use of pharmaceutical intermediates is expected to increase steadily over the forecast period.

Related reports:

Global market for dermatological lasers:

Global Bone Growth Stimulators Market:

Regional Performance of the Pharmaceutical Intermediates Market

Over the projected period, North America is expected to account for a considerable share of the global pharmaceutical intermediates market. The continent’s pharmaceutical intermediates market is expanding due to increased access to healthcare and rising incidence of chronic diseases.

Due to increased government spending on developing pharmaceutical midstream industries and improving medical infrastructure, Asia-Pacific is expected to become the most opportunistic market.

Moreover, China is the world’s largest importer of APIs, hence the demand for pharmaceutical intermediates is large in China. In addition, the government’s establishment of attractive international policies to attract FDI is expected to drive the growth of the region’s market.

Hindrances to the Growth of the Pharmaceutical Intermediates Market

Pharmaceutical midstream production is an expensive process that requires large purchases, knowledge of clinical trials, process improvement, technical requirements, and processing expertise.

Producers of pharmaceutical intermediates must engage in clinical studies and post-approval safety monitoring equipment comparable to original inventor companies.

Government and industry spending on R&D capabilities and facilities is expected to provide exciting prospects in the global pharmaceutical intermediates market. The growing R&D pipeline of Indian companies creates considerable licensing potential for foreign companies.

Government regulators around the world have put in place many stringent requirements and criteria for new pharmaceutical intermediates, which are expected to limit the market growth.

Many previously introduced intermediates had various severe side effects and were therefore not accepted by regulators. Such challenges for producers of pharmaceutical intermediates will hamper the global expansion of this industry.

Proceed to purchase:

overviewSLICE is a strategy and market intelligence consulting firm. The company provides tailored, ready-to-use market research. The company primarily focuses on strategy consulting to provide end-to-end solutions. For further details, please contact our research and advisory team at [email protected].

contact us:

Alex R

+1 707 736 6633

[email protected]

LinkedIn | Twitter